Projects funded by the NCN

Genetic mechanisms of drug resisntance in breast cancer patients treated with 5-fluorouracil, doxorubicine and cyclophos...

Call: PRELUDIUM 4 , Panel: NZ5

Principal investigator: dr Karolina Tęcza

Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie, Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie Oddział w Gliwicach

The examination of isothiocyanates influence on cytotoxic and cytostatic effects of 5-fluorouracil in cancer cell lines ...

Call: PRELUDIUM 3 , Panel: NZ5

Principal investigator: Małgorzata Milczarek

Narodowy Instytut Leków

The study of mechanisms that enhance the antitumor activity of 5-FU by the use of vitamin D analogs in human colon cance...

Call: PRELUDIUM 3 , Panel: NZ5

Principal investigator: dr Magdalena Milczarek

Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda PAN

Study of the interactions between PAMAM G5 and PAMAM G5-OH dendrimers and selected oncological drugs

Call: PRELUDIUM 3 , Panel: ST4

Principal investigator: dr Adam Buczkowski

Uniwersytet Łódzki, Wydział Chemii

The role of vitamin D receptor in 5-fluorouracil responsiveness of colorectal cancer cells

Call: SONATA 16 , Panel: NZ5

Principal investigator: dr Magdalena Milczarek

Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

Polymorphisms of miRNA genes and in the 3'UTR region of the ADME genes in breast cancer patients treated with FAC (5-flu...

Call: SONATA 11 , Panel: NZ5

Principal investigator: dr Jolanta Pamuła-Piłat

Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie - Państwowy Instytut Badawczy